Rentschler Biotechnology

Rentschler Biopharma SE is a leading family-owned contract development and manufacturing organization (CDMO) focused exclusively on biopharmaceuticals. The company provides a full range of services from process development and clinical supply to commercial manufacturing of complex biologics, including monoclonal antibodies and recombinant proteins. With headquarters in Laupheim, Germany, and a site in Milford, MA, USA, Rentschler supports clients globally through the entire value chain. Recently, the company expanded into advanced therapy medicinal products (ATMPs) through its dedicated site in Stevenage, UK, focusing on cell and gene therapy. Rentschler is known for its high-quality standards and its ability to handle difficult-to-express proteins using advanced technologies like the TurboCell platform.